Tag: Sarepta Therapeutics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Sarepta Therapeutics

BioPharma Credit net asset value and half-year profit both rise - Morningstar

Added to Collection on: 2022-09-14 09:57:14

Tags for this article:

Corvallis, Oregon
Sarepta Therapeutics
Industries
Health
BioPharma Credit PLC

Click the tags to see associated articles and topics

View Article Details
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is largely controlled by institutional ...

Added to Collection on: 2022-10-09 14:48:00

Tags for this article:

Finance
Money
Economy
Stock market
Corporate finance
Alternative investment management companies
Corvallis, Oregon
Sarepta Therapeutics
Stock
Hedge fund
Financial analyst
Citigroup
Sarepta Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Duchenne Muscular Dystrophy Market including top key players PTC Therapeutics

Added to Collection on: 2023-01-07 14:35:05

Tags for this article:

Life Sciences
Articles
Health
RTT
Biotechnology
Muscular dystrophy
BioMarin Pharmaceutical
Virotherapy
Sarepta Therapeutics
PTC Therapeutics
Duchenne
Deflazacort

Click the tags to see associated articles and topics

View Article Details
Novartis stops work on gene therapy acquired in Gyroscope deal - BioPharma Dive

Added to Collection on: 2023-09-11 16:23:01

Tags for this article:

Spinal muscular atrophy
Novartis
Intellia Therapeutics
Onasemnogene abeparvovec
Gene therapy
BioMarin Pharmaceutical
Sarepta Therapeutics
Novartis Gene Therapies

Click the tags to see associated articles and topics

View Article Details
Sarepta's muscular dystrophy therapy fails to meet main goal in late-stage trial | Reuters

Added to Collection on: 2023-10-30 21:52:01

Tags for this article:

Muscular dystrophy
Duchenne muscular dystrophy
Sarepta Therapeutics
Gene therapy
Dystrophin
Delandistrogene moxeparvovec
Therapy
DMD
Exon skipping
Drisapersen
SRPT.O

Click the tags to see associated articles and topics

View Article Details
[Ad hoc announcement pursuant to Art. 53 LR] Roche - GlobeNewswire

Added to Collection on: 2023-10-30 20:09:32

Tags for this article:

Muscular dystrophy
Biotechnology
Genetic engineering
Breakthrough therapy
Delandistrogene moxeparvovec
Gene therapy
Duchenne muscular dystrophy
Sarepta Therapeutics
Dystrophin
DMD
Dystrophin-associated protein complex
United States
Roche Group
Duchenne
Basel
Roche Founded

Click the tags to see associated articles and topics

View Article Details
5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024 - Yahoo Finance

Added to Collection on: 2024-03-08 18:25:55

Tags for this article:

Gilead Sciences
Sarepta Therapeutics
Earnings growth

Click the tags to see associated articles and topics

View Article Details
Wegovy packing supplier Catalent lays off 300 workers - Yahoo Finance

Added to Collection on: 2024-02-15 05:52:00

Tags for this article:

Research and development in the United States
Pharmacy
Novo Nordisk
Catalent
Biotechnology
Biotechnology products
AstraZeneca
Eli Lilly and Company
Pharmaceutical industry
Sarepta Therapeutics
Biopharmaceutical

Click the tags to see associated articles and topics

View Article Details
FDA Nod in Duchenne Helps Wider Swath of Patients With the Rare Muscle Disease

Added to Collection on: 2024-03-22 16:51:13

Tags for this article:

Biotechnology
Muscular dystrophy
Rare diseases
Genetic engineering
Duchenne muscular dystrophy
Applied genetics
Deflazacort
Delandistrogene moxeparvovec
Gene therapy
PTC Therapeutics
Exon skipping
Sarepta Therapeutics

Click the tags to see associated articles and topics

View Article Details
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?

Added to Collection on: 2024-03-29 21:19:46

Tags for this article:

Corvallis, Oregon
Sarepta Therapeutics
Roche
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details